Negative Pressure Suction for Oropharyngeal Dysphagia
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of California, Davis
No Placebo Group
Trial Summary
What is the purpose of this trial?
This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.
Research Team
Eligibility Criteria
This trial is for patients with oropharyngeal dysphagia who have a high risk of food entering their airway, rely on tube feeding, and haven't improved with standard treatments. It's not for those with severe throat narrowing, cognitive issues preventing cooperation, active cancer, no feeding tube, or recent cancer survivors.Inclusion Criteria
Patients with videofluoroscopic evidence of aspiration with Rosenbek Penetration Aspiration Scale (PAS) greater than 5 for all tested food consistencies
You rely on a feeding tube that goes through your stomach.
You have tried all standard treatment options, including physical therapy, medication, and surgery.
Exclusion Criteria
No gastrostomy tube present
Inability to follow commands
Vulnerable populations: adults unable to consent, pregnant women, and prisoners
See 3 more
Treatment Details
Interventions
- Negative Pressure Suction Catheter (Other)
Trial OverviewThe study tests if using a negative pressure suction catheter in the throat can reduce aspiration (food going into the lungs) during swallowing exams in people with difficulty swallowing.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Negative Pressure Suction DeviceExperimental Treatment1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
UC Davis Medical CenterSacramento, CA
Loading ...
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
Trials
958
Patients Recruited
4,816,000+